Statistical analysis
PPH
SECONDARY
Demographic, feasibility, safety, and clinical endpoints are summarized with appropriate measures of central tendency and dispersion. Categorical outcomes are presented as frequency and percent. Inferential analysis is presented to identify gross differences between groups, recognizing that a pilot trial is underpowered for PPH incidence and thus only exploratory in nature. Continuous secondary feasibility and clinical outcomes were analyzed using a t-test continuous outcomes and chi-square (χ